CGDG - ETF AI Analysis
Top Page
Capital Group Dividend Growers ETF (CGDG)
CGDG, the Capital Group Dividend Growers ETF, appears to be a solid-quality fund, supported by strong holdings like TSM, AVGO, and OKE, which benefit from robust financial performance, positive earnings sentiment, and strategic positioning in growth areas such as AI and energy infrastructure. The presence of more mixed names like PM and ABBV, where leverage, valuation, and financial stability concerns are noted, slightly tempers the overall picture, while the fund’s exposure to specific sectors like semiconductors and energy introduces some concentration risk if those areas face a downturn.
CGDG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 5.94B
- Region
- Global
- Expense Ratio
- 0.47%
- Beta
- 0.58
- Issuer
- Capital Group
- Inception Date
- Sep 26, 2023
- Dividend Yield
- 2.26%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
CGDG Summary
Capital Group Dividend Growers ETF (CGDG) is an actively managed fund that focuses on companies around the world that regularly increase their dividend payments, rather than tracking a specific index. It holds a mix of large, mid, and small companies across many sectors, with big positions in well-known names like Broadcom and AbbVie. Someone might invest in CGDG to seek a combination of steady income from dividends and long-term growth, while getting global diversification. A key risk is that stock prices and dividend payments can go up and down with the market, so your investment value is not guaranteed.
How much will it cost me?
This ETF has an expense ratio of 0.47%, which means you’ll pay about $4.70 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because CGDG is actively managed, with professionals selecting dividend-growing companies rather than simply tracking a market index.
What would affect this ETF?
CGDG could benefit if global economic growth stays steady, as its mix of financials, technology, and health care stocks and focus on companies that raise dividends may support rising income and share prices, especially for major holdings like TSMC, Broadcom, and AbbVie. On the other hand, higher interest rates, stricter regulations on tobacco and energy companies, or a global slowdown that pressures dividend payments and real estate and utility sectors could weigh on the ETF’s future performance.
CGDG Top 10 Holdings
CGDG leans on a mix of global dividend powerhouses, with Taiwan’s TSMC and Broadcom giving the fund a strong semiconductor backbone. TSMC has been rising over the year, helping drive returns, while Broadcom’s more mixed recent performance keeps it from fully pulling its weight. On the income side, Philip Morris and British American Tobacco have been steady to rising, acting like ballast when markets wobble. Health care names like AbbVie are climbing, and energy player TotalEnergies has been a bright spot, adding fuel to performance. Overall, it’s a globally diversified, dividend-focused portfolio with a noticeable tilt toward tech, health care, and defensive consumer names.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 TSM | TSMC | 4.17% | $247.19M | $1.88T | 33.94% | 81Outperform |
 PM | Philip Morris | 4.29% | $254.21M | $325.43B | 43.24% | 61Neutral |
 AVGO | Broadcom | 3.73% | $221.13M | $1.56T | -13.38% | 76Outperform |
 ABBV | AbbVie | 2.22% | $131.39M | $521.11B | 29.22% | 66Neutral |
 WELL | Welltower | 2.14% | $126.86M | $172.10B | 29.70% | 77Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 FR:TTE | TotalEnergies SE | 2.00% | $118.32M | EUR 190.70B | 59.27% | 78Outperform |
 GB:BATS | British American Tobacco | 1.85% | $109.97M | GBP 98.70B | 17.93% | 71Outperform |
 RCL | Royal Caribbean | 1.64% | $96.98M | $82.16B | 7.96% | 67Neutral |
 ES:IBE | Iberdrola | 1.56% | $92.36M | EUR 146.27B | 26.31% | 67Neutral |
CGDG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CGDG, the sentiment is Positive. The current price of 38.43 is above the 20-day moving average (MA) of 37.74, above the 50-day MA of 37.88, and above the 200-day MA of 37.06, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 63.87 is Neutral, neither overbought nor oversold. The STOCH value of 89.30 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CGDG.
CGDG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| CGDG | $38.43 | $41.00(6.69% Upside) | $5.94B | 0.47% | 68Neutral |
 JGLO | $70.74 | $89.95(27.16% Upside) | $6.29B | 0.47% | 71Outperform |
 CGGE | $33.92 | $43.11(27.09% Upside) | $3.30B | 0.47% | 68Neutral |
 BDYN | $27.10 | $32.71(20.71% Upside) | $3.16B | 0.39% | 66Neutral |
 BFLX | $25.25 | $30.41(20.42% Upside) | $2.21B | 0.40% | 70Neutral |
 BDVL | $26.48 | $31.12(17.50% Upside) | $1.79B | 0.39% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CGDG | Capital Group Dividend Growers ETF | 38.43 | 4.45 | 13.10% | |
| JGLO | JPMorgan Global Select Equity ETF | 70.74 | 3.35 | 4.98% | |
| CGGE | Capital Group Global Equity ETF | 33.92 | 2.77 | 8.87% | |
| BDYN | iShares Dynamic Equity Active ETF | 27.10 | 1.69 | 6.66% | |
| BFLX | iShares Flexible Equity Active ETF | 25.25 | -0.02 | -0.09% | |
| BDVL | iShares Disciplined Volatility Equity Active ETF Trust Unit | 26.48 | 2.33 | 9.64% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.